Overview

A Study of Tadalafil (LY450190) in Chinese Men With Erectile Dysfunction

Status:
Completed
Trial end date:
2017-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and effectiveness of the study drug, taken once daily, known as tadalafil in Chinese participants with erectile dysfunction (ED). The study will last about up to 25 months for each participant.
Phase:
Phase 4
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Tadalafil